JANE STREET GROUP, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 78 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2021. The put-call ratio across all filers is 2.29 and the average weighting 1.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$154,000
+227.7%
35,924
+221.5%
0.00%
Q1 2021$47,000
-64.9%
11,173
-21.4%
0.00%
Q4 2018$134,000
-33.0%
14,218
+147.0%
0.00%
-100.0%
Q3 2017$200,000
-9.1%
5,756
-71.8%
0.00%
-50.0%
Q1 2014$220,00020,3810.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders